- Home
- KODK vs PRME Comparison
KODK vs PRME Comparison
Compare KODK & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KODK
- PRME
- Stock Information
- Founded
- KODK 1880
- PRME 2019
- Country
- KODK United States
- PRME United States
- Employees
- KODK N/A
- PRME N/A
- Industry
- KODK Business Services
- PRME Medicinal Chemicals and Botanical Products
- Sector
- KODK Consumer Discretionary
- PRME Health Care
- Exchange
- KODK Nasdaq
- PRME Nasdaq
- Market Cap
- KODK 423.7M
- PRME 424.9M
- IPO Year
- KODK N/A
- PRME 2022
- Fundamental
- Price
- KODK $6.87
- PRME $2.90
- Analyst Decision
- KODK
- PRME Strong Buy
- Analyst Count
- KODK 0
- PRME 9
- Target Price
- KODK N/A
- PRME $13.13
- AVG Volume (30 Days)
- KODK 2.5M
- PRME 1.3M
- Earning Date
- KODK 11-12-2024
- PRME 11-12-2024
- Dividend Yield
- KODK N/A
- PRME N/A
- EPS Growth
- KODK 0.52
- PRME N/A
- EPS
- KODK 0.71
- PRME N/A
- Revenue
- KODK $1,052,000,000.00
- PRME $800,000.00
- Revenue This Year
- KODK N/A
- PRME N/A
- Revenue Next Year
- KODK N/A
- PRME $426.55
- P/E Ratio
- KODK $9.66
- PRME N/A
- Revenue Growth
- KODK N/A
- PRME N/A
- 52 Week Low
- KODK $3.33
- PRME $2.56
- 52 Week High
- KODK $7.74
- PRME $9.80
- Technical
- Relative Strength Index (RSI)
- KODK 56.81
- PRME 41.76
- Support Level
- KODK $6.74
- PRME $2.56
- Resistance Level
- KODK $7.56
- PRME $3.04
- Average True Range (ATR)
- KODK 0.47
- PRME 0.25
- MACD
- KODK -0.06
- PRME -0.01
- Stochastic Oscillator
- KODK 36.70
- PRME 36.17
About KODK Eastman Kodak Company Common New
Eastman Kodak Co is a United States-based company. The company operates via several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.